Diagnostic performance of a receptor-binding radiopharmacokinetic model

Journal of Nuclear Medicine

Volumn 37, Issue 1, 1996, Pages 160-164

  Vera, David R ^a   Stadalnik, Robert C ^b   Metz, Charles E ^b   Pimstone, Neville R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

radiopharmacokinetic modeling; receiver operating characteristics; receptor binding radiopharmaceuticals; technetium 99m galactosyl neoglycoalbumin

Indexed keywords

ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; MALE; PLASMA VOLUME; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING;

ALBUMINS; CASE-CONTROL STUDIES; HEART; HUMANS; LIVER; LIVER DISEASES; MODELS, BIOLOGICAL; ORGANOTECHNETIUM COMPOUNDS; RECEPTORS, CELL SURFACE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; TISSUE DISTRIBUTION;

EID: 0029884990     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Stadalnik RC, Kudo M, Eckelman WC, Vera DR. In vivo functional imaging using receptor-binding radiopharmaceuticals: technetium-99m-galactosyl-neoglycoalbumin as a model Invest Radiol 1993;28:64-70.
2. 99mTc]galactosyl-neoglycoalbumin J Nucl Med 1991,31:1169-1176.
3. Stadalnik RC, Vera DR, Woodle ES, et al Technetium-99m-NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med 1985;26:1233-1242.
4. Kudo M, Vera DR, Stadalnik RC, Trudeau WL, Ikekubo K, Kudo A. In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve. Am J Gastroenterol 1990;85,1142-1148.
5. Virgolini I, Müller C, Klepetko W, et al. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte-specific galactosylated radioligand. Br J Cancer 1990;61 937-941.
6. 99mTc-galactosyl-neoglycoalbumin Hepatology 1992;15:593-598.
7. Kudo M, Todo A, Ikekubo K, Yamamoto K, Vera DR, Stadalnik RC. Quantitative assessment of hepatocellular function via in vivo radioreceptor imaging technetium-99m-galactosyl human serum albumin (Tc-GSA) Hepatology 1993;17 814-819.
8. Virgolini I, Kornek G, Höbart J, et al Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer Br J Cancer 1993;68 549-554
9. Pimstone NR, Stadalnik RC, Vera DR, Ilutak DP, Trndeau WL. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analogue Hepatology 1994;20:917-923.
10. Metz CE ROC Methodology in radiologic imaging Invest Radiol 1986;21 720-733
11. Vera DR, Stadalnik RC, Krohn KA Technetium-99m-galactosyl-neoglycoalbumin. preparation and preclinical studies. J Nucl Med 1985;26:1157-1167.
12. Vera DR, Scheibe PO, Krohn KA, Trudeau WL, Stadalnik RC. Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Eng 1992;BME-39 356-367.
13. 14C]aminopyrine breath test in liver disease Gut 1978,19 40-45.
14. Metz CE, Wang P-L, Kronman HB. A new approach for testing the significance of differences between ROC curves measured from correlated data. In: Deconinck F, ed Information processing in medical imaging. The Hague: Nijhoff; 1984.432-445
15. Metz CE, Shen J-H, Herman BA. New methods for estimating a binormal ROC curve from continuously-distributed test results. 1990 Joint Statistical Meetings of the American Statistical Society and the Biometric Society. Anaheim, CA, 1990
16. Metz CE Quantification of failure to demonstrate statistical significance: the usefulness of confidence intervals. Invest Radiol 1993;28:59-63.
17. Moore WJ. Physical chemistry. 4th ed. Englewood Cliffs, NJ: Prentice-Hall. 1972.
18. Paumgartner G, Probst P, Krames R, Leevy CM. Kinetics of indocyanine green removal from the blood. Ann NY Acad Sci 1970;170 134-147.
19. Moody FG, Rikkers LF, Aldrete JS. Estimation of the functional reserve of human liver. Ann Surg 1974;180-592-598.
20. 99mTc]galactosyl-neoglycoalbumin. Dig Dis Sci 1993;38 2183-2188.
21. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. Technetium-99m-galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding. J Nucl Med 1984,25:779-787.
22. Vera DR, Krohn KA, Scheibe PO, Stadalnik RC. Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system IEEE Trans Biomed Eng 1985.BME-32:312-322
23. Vera DR, Scheibe PO, Banin Y, Stadalnik RC Local identifiability of a receptor-binding radiopharmacokinetic system having parameters of known uncertainty IEEE Trans Biomed Eng 1994,BME-41:891-897
24. Stadalnik RC, Vera DR, Krohn KA. Receptor-binding radiopharmaceuticals Experimental and clinical aspects. In: Freeman LM, Weissman HS, eds. Nuclear medicine annual 1986 New York: Raven Press, 1986.105-139